QT Imaging Registers 29.3M Shares for Resale Amidst Capital Raises, Reverse Split

Ticker: QTIWW · Form: S-1/A · Filed: Dec 29, 2025 · CIK: 1844505

Qt Imaging Holdings, Inc. S-1/A Filing Summary
FieldDetail
CompanyQt Imaging Holdings, Inc. (QTIWW)
Form TypeS-1/A
Filed DateDec 29, 2025
Risk Levelhigh
Pages15
Reading Time19 min
Key Dollar Amounts$0.0001, $10,100,000, $5,000,000, $15,100,000, $0.40
Sentimentbearish

Sentiment: bearish

Topics: S-1/A Filing, Share Resale, Private Placement, Reverse Stock Split, Debt Financing, Dilution Risk, Medical Imaging

Related Tickers: QTIH, QTIWW

TL;DR

**Sell-side pressure is imminent for QTIWW as over 29 million shares hit the market, likely depressing prices despite recent capital injections.**

AI Summary

QT Imaging Holdings, Inc. (QTIWW) filed an S-1/A on December 29, 2025, primarily for the resale of up to 29,336,017 shares of common stock by selling securityholders. The company will not receive proceeds from these sales, but will from warrant exercises, which will be used for general corporate purposes. Key financial activities include a senior secured term loan from Lynrock Lake Master Fund LP, initially for $10,100,000 at 10.0% interest on February 26, 2025, and subsequently increased by $5,000,000 to $15,100,000 on August 26, 2025. The company also completed three private placements in 2025, raising approximately $500,000 from the First Private Placement, $200,000 from the Second Private Placement, and $18,180,655 from the Third Private Placement. A 3:1 reverse stock split became effective on October 23, 2025, adjusting share counts and warrant exercise prices. The closing price of QTIH common stock was $5.95 and QTIWW public warrants was $0.114 on December 26, 2025. A significant risk is the potential for market price reduction due to substantial sales by selling securityholders, who acquired shares at a lower effective price.

Why It Matters

This S-1/A filing signals a significant potential for dilution and downward pressure on QT Imaging's stock price, as selling securityholders are poised to offload 29,336,017 shares. Investors should be wary of the substantial volume of shares entering the market, especially since many were acquired at a lower effective price, allowing early investors to profit even if the stock declines. For employees and customers, the capital raises, totaling over $18.8 million from private placements and $15.1 million in debt, could provide necessary funding for operations and product development, but the overhang of potential share sales creates uncertainty. The competitive landscape for medical imaging is intense, and QT Imaging's ability to leverage this capital for innovation and market penetration will be critical to counter the selling pressure.

Risk Assessment

Risk Level: high — The risk level is high due to the registration of 29,336,017 shares for resale by selling securityholders, representing a significant portion of the company's common stock. The filing explicitly states that "sales of a substantial number of shares of Common Stock in the public market... could reduce the market price of the Common Stock." Furthermore, these selling securityholders purchased shares at an "effective price lower than the current market price," creating a strong incentive for them to sell and realize profits, potentially at the expense of other stockholders.

Analyst Insight

Investors should exercise extreme caution and consider reducing exposure to QTIWW given the impending flood of 29,336,017 shares from selling securityholders. The potential for significant downward price pressure is high, and new investors should wait for the market to absorb this supply before considering an entry point, as the current $5.95 closing price on December 26, 2025, may not hold.

Key Numbers

  • $29,336,017 — Shares of Common Stock (Maximum shares registered for resale by Selling Securityholders)
  • $15,100,000 — Aggregate Principal Amount (Senior secured term loan from Lynrock Lake Master Fund LP after amendment)
  • 10.0% — Interest Rate (Annual interest rate on the senior secured term loan)
  • $500,000 — Gross Proceeds (From the First Private Placement on April 9, 2025)
  • $200,000 — Gross Proceeds (From the Second Private Placement on May 12, 2025)
  • $18,180,655 — Gross Proceeds (From the Third Private Placement on October 3, 2025)
  • 3:1 — Reverse Stock Split Ratio (Effective October 23, 2025)
  • $5.95 — Closing Price of Common Stock (QTIH) (On December 26, 2025)
  • $0.114 — Closing Price of Public Warrants (QTIWW) (On December 26, 2025)
  • 20,333,623 — Shares Issuable (Upon exercise of Lynrock Lake Warrant after reverse split)

Key Players & Entities

  • QT Imaging Holdings, Inc. (company) — Registrant and issuer of securities
  • Lynrock Lake Master Fund LP (company) — Senior secured term loan provider and warrant holder
  • Dr. Raluca Dinu (person) — Chief Executive Officer and First Purchaser in private placement
  • Dr. Avi Katz (person) — Chairman of the Board of Directors and First Purchaser in private placement
  • Leon Recanati (person) — Second Purchaser in private placement
  • Sio Capital Management, LLC (company) — Lead investor in the Third Private Placement
  • U.S. Securities and Exchange Commission (regulator) — Regulatory body for the S-1/A filing
  • DLA Piper LLP (US) (company) — Legal counsel for the registrant
  • Jeffrey C. Selman (person) — Legal counsel from DLA Piper LLP (US)
  • Elena Nrtina (person) — Legal counsel from DLA Piper LLP (US)

FAQ

What is the purpose of QT Imaging Holdings, Inc.'s S-1/A filing?

The S-1/A filing by QT Imaging Holdings, Inc. is primarily for the registration of up to 29,336,017 shares of common stock for resale by existing selling securityholders. The company itself will not receive any proceeds from these specific sales, but will receive proceeds if warrants are exercised for cash, which will be used for general corporate purposes.

How much debt financing did QT Imaging Holdings, Inc. secure in 2025?

QT Imaging Holdings, Inc. secured a senior secured term loan from Lynrock Lake Master Fund LP. Initially, the loan was for $10,100,000 on February 26, 2025, at a 10.0% interest rate. This was subsequently increased by an additional $5,000,000 on August 26, 2025, bringing the aggregate principal amount to $15,100,000.

What was the impact of the reverse stock split on QT Imaging Holdings, Inc. shares?

QT Imaging Holdings, Inc. effected a 3:1 reverse stock split, which became effective on October 23, 2025. This reduced the number of outstanding shares and adjusted the exercise prices and share counts of warrants, such as the Lynrock Lake Warrant, which was adjusted from 61,000,000 shares at $0.40 to 20,333,623 shares at $1.20.

Who are the key investors in QT Imaging Holdings, Inc.'s private placements?

Key investors in QT Imaging Holdings, Inc.'s private placements include Dr. Avi Katz (Chairman of the Board) and Dr. Raluca Dinu (CEO) in the First Private Placement, Leon Recanati in the Second Private Placement, and Sio Capital Management, LLC, leading a group of accredited investors in the Third Private Placement.

What are the total gross proceeds from QT Imaging Holdings, Inc.'s private placements in 2025?

QT Imaging Holdings, Inc. completed three private placements in 2025, generating aggregate gross proceeds of approximately $500,000 from the First Private Placement, $200,000 from the Second Private Placement, and $18,180,655 from the Third Private Placement, totaling approximately $18,880,655.

What is the primary risk for investors in QT Imaging Holdings, Inc. as highlighted in the S-1/A?

The primary risk highlighted is the potential for significant downward pressure on the common stock's market price due to the resale of 29,336,017 shares by selling securityholders. These securityholders acquired their shares at an effective price lower than the current market price, creating an incentive for them to sell and potentially reduce the stock's value for other investors.

Will QT Imaging Holdings, Inc. receive cash from the sale of shares by selling securityholders?

No, QT Imaging Holdings, Inc. will not receive any proceeds from the direct sale of shares by the selling securityholders. The company will only receive proceeds if the Warrants are exercised for cash, which is dependent on the market price of the common stock exceeding the warrant exercise price.

What were the closing prices for QT Imaging Holdings, Inc. stock and warrants on December 26, 2025?

On December 26, 2025, the closing price for QT Imaging Holdings, Inc.'s common stock (QTIH) was $5.95, and the closing price for its public warrants (QTIWW) was $0.114.

What is an 'emerging growth company' and how does it apply to QT Imaging Holdings, Inc.?

QT Imaging Holdings, Inc. is an 'emerging growth company' as defined in Section 2(a) of the Securities Act of 1933. This designation allows the company to comply with reduced public company reporting requirements, which can include less extensive disclosure obligations compared to larger, more established companies.

What is the potential duration of market pressure from the registered shares for QT Imaging Holdings, Inc.?

The filing indicates that due to the large number of shares being registered, the selling securityholders are expected to continue offering these securities for a "significant period of time," the precise duration of which cannot be predicted. This suggests that adverse market and price pressures could persist for an extended period.

Risk Factors

  • Dilution from Resale of Shares [high — market]: The resale of up to 29,336,017 shares by selling securityholders could significantly depress the market price of the company's common stock. Many of these shares were acquired at a substantially lower effective price than the current market price, creating an incentive for immediate sale.
  • Debt Obligations and Interest Expense [medium — financial]: The company has a senior secured term loan of $15,100,000 with a 10.0% annual interest rate. This substantial debt, along with potential future financing needs, increases financial risk and the burden of interest payments.
  • Dependence on Future Financing [medium — financial]: The company has relied on private placements and debt financing to fund its operations. Continued reliance on external financing, especially at potentially unfavorable terms, poses a risk to financial stability and growth.
  • Volatility of Public Warrant Value [medium — market]: The public warrants (QTIWW) closed at $0.114 on December 26, 2025, indicating low market valuation and high volatility. This suggests significant uncertainty about the company's future prospects as perceived by the market.
  • Reverse Stock Split Impact [low — operational]: The 3:1 reverse stock split effective October 23, 2025, while adjusting share counts and warrant prices, can sometimes be perceived negatively by the market and may not fully address underlying business challenges.

Industry Context

QT Imaging Holdings operates in the medical imaging technology sector. This industry is characterized by rapid technological advancements, significant R&D investment, and a complex regulatory environment overseen by bodies like the FDA. Competition often comes from established players with extensive market reach and newer entrants focusing on niche applications or disruptive technologies.

Regulatory Implications

As a medical imaging company, QT Imaging Holdings is subject to stringent regulatory oversight, particularly concerning product development, testing, and marketing approvals from agencies like the FDA. Compliance with these regulations is critical and can significantly impact timelines and costs associated with bringing new technologies to market.

What Investors Should Do

  1. Monitor Selling Shareholder Activity
  2. Evaluate Debt Structure and Repayment Capacity
  3. Assess Future Capital Needs and Dilution Risk
  4. Analyze Warrant Exercise Dynamics

Key Dates

  • 2025-02-26: Initial Senior Secured Term Loan — Secured $10,100,000 in debt financing from Lynrock Lake Master Fund LP, crucial for operations but adding leverage.
  • 2025-04-09: First Private Placement — Raised $500,000, indicating early-stage funding efforts and investor interest.
  • 2025-05-12: Second Private Placement — Raised $200,000, continuing reliance on private capital.
  • 2025-08-26: Term Loan Amendment — Increased the senior secured term loan by $5,000,000 to $15,100,000, reflecting ongoing funding needs.
  • 2025-10-03: Third Private Placement — Raised a significant $18,180,655, providing substantial capital but likely at dilutive terms.
  • 2025-10-23: 3:1 Reverse Stock Split — Adjusted share structure and warrant terms, potentially impacting market perception and share price mechanics.
  • 2025-12-29: S-1/A Filing — Registered for resale of shares by selling securityholders, highlighting potential market overhang and lack of proceeds to the company.

Glossary

S-1/A
An amended registration statement filed with the SEC, typically used when a company is going public or has previously filed an S-1 and needs to make changes. (This filing indicates the company is providing updated information regarding the resale of securities.)
Selling Securityholders
Entities or individuals who own securities and intend to sell them in the public market. (In this filing, these holders are registering shares for resale, which could impact market supply and price.)
Senior Secured Term Loan
A type of loan that is backed by specific collateral and has priority over other unsecured debts in case of default. (The company has a significant term loan, impacting its financial leverage and risk profile.)
Private Placement
The sale of securities to a select group of investors, rather than through a public offering. (The company has raised capital through multiple private placements, indicating reliance on this funding method.)
Reverse Stock Split
A corporate action where a company reduces the total number of its outstanding shares by consolidating existing shares into fewer, proportionally more valuable shares. (QTIWW underwent a 3:1 reverse stock split, affecting share counts and potentially stock price perception.)
Warrants
Securities that give the holder the right, but not the obligation, to purchase a company's stock at a specified price (exercise price) before a certain expiration date. (The filing involves the resale of shares underlying warrants, and the company has outstanding warrants (QTIWW).)

Year-Over-Year Comparison

This S-1/A filing focuses on the resale of shares by existing securityholders and details recent financing activities, including a significant term loan and multiple private placements. Unlike a typical IPO filing, it does not appear to be raising primary capital for the company, and therefore, direct comparisons of revenue growth, margin changes, or new risks from a prior year's operational filing are not directly applicable based on the provided context. The primary focus is on the liquidity event for existing shareholders and the company's current debt structure.

Filing Stats: 4,630 words · 19 min read · ~15 pages · Grade level 17.2 · Accepted 2025-12-29 16:02:33

Key Financial Figures

  • $0.0001 — 7 shares of the common stock, par value $0.0001 per shares (the " Common Stock "), of Q
  • $10,100,000 — ke in the aggregate principal amount of $10,100,000 at an interest rate of 10.0% per annum.
  • $5,000,000 — ment ") to add an additional tranche of $5,000,000 to the loan and increase the aggregate
  • $15,100,000 — rease the aggregate principal amount to $15,100,000. In connection with the Credit Agreemen
  • $0.40 — of Common Stock at an exercise price of $0.40 per share (the " Lynrock Lake Warrant "
  • $1 — ce have been adjusted to 20,333,623 and $1.20, respectively. On April 9, 2025, th
  • $2.16 — e Stock Split have an exercise price of $2.16 per share and are exercisable for an ag
  • $500,000, b — st Private Placement were approximately $500,000, before deducting the placement agent fees
  • $200,000, b — nd Private Placement were approximately $200,000, before deducting the placement agent fees
  • $18,180,655, b — rd Private Placement were approximately $18,180,655, before deducting the placement agent fees
  • $5 — e closing price of our Common Stock was $5.95, and on December 26, 2025, the closi
  • $0.114 — osing price for our Public Warrants was $0.114. We are an "emerging growth company" a

Filing Documents

USE OF PROCEEDS

USE OF PROCEEDS 73 PRIVATE PLACEMENT OF SHARES OF COMMON STOCK AND WARRANTS 74 DIVIDEND POLICY 76 DETERMINATION OF OFFERING PRICE 77 SUMMARY HISTORICAL FINANCIAL INFORMATION OF QT IMAGING 78

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 79

BUSINESS

BUSINESS 101 MANAGEMENT 156

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 168 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 170 OTHER MATERIAL AGREEMENTS 174 PRINCIPAL SECURITYHOLDERS 177 SELLING SECURITYHOLDERS 179 DESCRIPTION OF OUR SECURITIES 182 MATERIAL UNITED STATES FEDERAL INCOME TAX CONSEQUENCES 192 PLAN OF DISTRIBUTION 198 LEGAL MATTERS 201 EXPERTS 201 WHERE YOU CAN FIND MORE INFORMATION 201 INDEX TO FINANCIAL STATEMENTS F-1

INFORMATION NOT REQUIRED IN PROSPECTUS

PART II INFORMATION NOT REQUIRED IN PROSPECTUS II-1 EXHIBIT INDEX II-7

SIGNATURES

SIGNATURES II-13 i Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-1 that we filed with the Securities and Exchange Commission (the " SEC ") using the "shelf" registration process. Under this shelf registration process, the Selling Securityholders may, from time to time, sell the securities offered by them described in this prospectus. We will not receive any proceeds from the sale by such Selling Securityholder of the securities offered by them described in this prospectus. This prospectus also relates to the issuance by us of the shares of the Common Stock issuable upon the exercise of any Warrants. We will not receive any proceeds from the sale of shares of the Common Stock underlying the Warrants pursuant to this prospectus, except with respect to amounts received by us upon the exercise of the Warrants for cash. The exercise of the Warrants, and any proceeds we may receive from any their exercise, are highly dependent on the price of any our shares of the Common Stock and the spread between the exercise price of the Warrants and the price of our Common Stock at the time of exercise. If the market price of our Common Stock is less the exercise price of a holder's Warrants, it is unlikely that holders will exercise their Warrants. There can be no assurance that our Warrants will be in the money prior to their expiration. Neither we nor the Selling Securityholders have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or any applicable prospectus supplement or any free writing prospectuses prepared by or on behalf of us or to which we have referred you. Neither we nor the Selling Securityholders take responsibility for, or provide any assurance as to the reliability of, any other information that others may give you. Neither we nor the Selling Securityholders will make an offer to sell these securities in any jurisdiction

View Full Filing

View this S-1/A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.